Insilico Medicine signs strategic research collaboration with Sanofi worth $1.2 B

Hong Kong-based startup Insilico Medicine has announced a multi-year, multi-target strategic research collaboration with...

November 9, 2022 | Wednesday | News
Takeda donates Fomepizole to address acute kidney injury crisis in Indonesia

PT. Takeda Indonesia has provided a donation of fomepizole, an approved medicine in Japan, indicated for treating ...

November 2, 2022 | Wednesday | News
Eisai divests rights of select products in Asia to DKSH

Japanese firm Eisai Co. has entered into an agreement to divest its rights for muscle relaxant Myonal (generic name: epe...

November 7, 2022 | Monday | News
SinoMab appoints new President for China operations

SinoMab BioScience, a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing an...

November 7, 2022 | Monday | News
SK bioscience announces new strategy for continuous growth

South Korea-based SK bioscience has announced a future growth strategy to secure global top-tier vaccine development cap...

November 7, 2022 | Monday | News
Ono Pharma receives approval for mAb treatment of NSCLC in South Korea

Japan's Ono Pharmaceutical has announced that its Korean subsidiary of ONO, has received the approval of Opdivo (nivol...

October 30, 2022 | Sunday | News
Building Resilience in Pharmaceutical and Biologic Manufacturing

The pandemic exposed the depth of challenges that manufacturers are facing, including supply chain disruption, skilled w...

October 31, 2022 | Monday | Opinion
“The most intriguing aspect of diabetes care is the relentless pursuit of orally active insulin”

What are the latest developments in diabetes treatment drugs and therapeutics in Asia and globally as well?  It is...

November 7, 2022 | Monday | Opinion
Invincible Diabetes Turns APAC Into Pharma Goldmine

On October 10, 2022, Chinese firm Hua Medicines snagged the first-in-class nod in China for a diabetes drug Dorzagliatin...

October 31, 2022 | Monday | Analysis
Telix, UniQuest to collaborate on radiolabelled immune targeting peptide

Australia-based Telix Pharmaceuticals has announced a collaboration with UniQuest, the commercialisation company of The ...

October 28, 2022 | Friday | News
Singapore's GIC invests in German firm CHEPLAPHARM

CHEPLAPHARM AG, a leading international platform for well-established branded medicines, has entered into a definitive a...

October 26, 2022 | Wednesday | News
Sanofi adds 3D Experience to manufacturing facilities at Singapore, France

Dassault Systèmes and Sanofi have announced their partnership to optimise “EVolutive Facilit...

October 27, 2022 | Thursday | News
Japan-based Sumitovant Biopharma to acquire Myovant Sciences for $1.7 B

Sumitovant Biopharma, a wholly owned subsidiary of Japanese firm Sumitomo Pharma Co., and Switzerland & US-base...

October 27, 2022 | Thursday | News
Singapore Week of Innovation and Technology (SWITCH) kickstarts unveiling Global-Asia innovation ecosystem

Onsite Coverage By Hithaishi Bhaskar The seventh edition of "Singapore Week of Innovation and Technology" (SWITCH) 2022...

October 25, 2022 | Tuesday | News
Japan's Astellas Pharma invests $50 M to support gene therapy programmes of Taysha

Japan-based Astellas Pharma Inc. and Taysha Gene Therapies, Inc. have announced a strategic investment to support t...

October 25, 2022 | Tuesday | News
Takeda enters new collaboration to develop first-in-class celiac disease therapy

Japanese pharmaceutical firm Takeda, and Germany-based Zedira and Dr. Falk Pharma GmbH have announced a collaborati...

October 22, 2022 | Saturday | News
AUM Biosciences to be publicly listed following merger with Mountain Crest

Singapore-based AUM Biosciences and Mountain Crest Acquisition Corp. V (in the US) have entered into a definitive busine...

October 21, 2022 | Friday | News
Korea's LG Chem to acquire AVEO Oncology for $566 M

South Korean chemical company LG Chem has announced a definitive agreement with AVEO Oncology in which LG Chem will...

October 20, 2022 | Thursday | News
GenScript ProBio signs MOU with GeneCraft for new AAV gene therapies

GenScript ProBio, a global CDMO, and GeneCraft, a global research team led by Professor Suk Chul Bae of lung cancer...

October 18, 2022 | Tuesday | News
Galderma to expand manufacturing and innovation footprint in Asia-Pacific

Reaffirming its bold ambition to become the leading dermatology company in the world, Swiss pharmaceutical company Galde...

October 14, 2022 | Friday | News
Joyce Lee joins Moderna as General Manager of Taiwan and Cluster Lead

US-based pharmaceutical firm Moderna has announced the appointment of Joyce Lee as the General Manager of Taiwan an...

October 7, 2022 | Friday | News
Emerging Southeast pharma nations to grow faster than Singapore

The pharma industry in Southeast Asia has scored a significant increase of nearly 20 percent for ‘growth potential...

October 10, 2022 | Monday | News
Lupin partners with global agencies to support tuberculosis prevention

Indian pharma major Lupin has reached an agreement with Unitaid, The Aurum Institute, the Clinton Health Access Initiati...

October 7, 2022 | Friday | News
BIO Asia Taiwan 2022 Showcases Innovation, Market, Supply and Investment

By Hithaishi Bhaskar BIO Asia–Taiwan 2022 International Conference and Exhibition was held in Taiwan’s...

October 6, 2022 | Thursday | News
MSD to inject $500M over five years into new manufacturing facility in Singapore

Singapore will soon host a new MSD (Merck & Co., in the U.S. and Canada) secondary packaging facility to support the...

October 5, 2022 | Wednesday | News